OAC
TIL icon

OMERS Administration Corp’s Instil Bio TIL Stock Holding History

OMERS Administration Corp’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,700
Closed -$325K – 1086
2025
Q1 		$325K Buy
+18,700
New +$388K ﹤0.01% 840
2024
Q4 		– Sell
-3,800
Closed -$256K – 1055
2024
Q3 		$256K Buy
+3,800
New +$89.5K ﹤0.01% 768

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

OMERS Administration Corp's TIL Position: Q2 2025 in Review

OMERS Administration Corp sold out of Instil Bio (TIL) in Q2 2025, closing a stake of 18,700 shares — an estimated $325K sold.

OMERS Administration Corp first reported a position in TIL in Q3 2024 and held it in 2 quarters. The position peaked at $325K in Q1 2025. 38 funds tracked by Wall St. Rank hold TIL as of Q2 2025.

  • OMERS Administration Corp reported no remaining Instil Bio position as of Q2 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 18,700 Instil Bio shares in Q2 2025, an estimated $325K.
  • OMERS Administration Corp first reported a position in Instil Bio in Q3 2024 and held it in 2 quarters.
  • OMERS Administration Corp's Instil Bio position peaked at $325K in Q1 2025.
  • 38 funds tracked by Wall St. Rank held Instil Bio as of Q2 2025.

Based on OMERS Administration Corp's 13F filing for Q2 2025, filed 13 Aug 2025.